Breaking News

Asahi Kasei Bioprocess Introduces THESYS ACS ERGO Synthesis Column

Offers reduced changeover time between batches while maintaining user safety and product quality.

Author Image

By: Charlie Sternberg

Associate Editor

Asahi Kasei Bioprocess (AKB) has unveiled the THESYS ACS ERGO synthesis column, its latest oligo manufacturing innovation which offers reduced changeover time between batches while maintaining user safety and product quality.   Following the success of AKB’s DAC ERGO, a liquid chromatography column, the company has continued advancing column technology. The THESYS ACS ERGO is designed for oligonucleotide synthesis and includes an operator-friendly design to facilitate a smooth and safe changeo...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters